Biotechnology FDA Approves Mirum’s Livmarli For Liver Disease In Kids As Young As 5 Years: Analyst Bullish On Label Expansion Strategy – Mirum Pharmaceuticals (NASDAQ:MIRM) Read more
Biotechnology FDA Approves Pfizer’s Leukemia Drug For Kids As Old As One Year – Pfizer (NYSE:PFE) Read more